Wockhardt Latest Indian Drug Maker To Split Off R&D
This article was originally published in PharmAsia News
Executive Summary
India's Wockhardt plans to form its research and development business into a new company to be listed on the stock exchange in 2009. Wockhardt would become the latest of several major drug makers in India to split their R&D work from their other drug-development activities. The separation is seen by companies as a way to raise more funds to support research while reducing the risks to core business. But one analyst said Wockhardt is not likely to see the benefits of delisting as much as its rivals because its drug pipeline is small. (Click here for more